BCRX
BioCryst Pharmaceuticals Inc
8.80$
+0.9%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +254.6% | -45.4% | -4.4% | -18.0% | +136.5% | -63.5% | +782.4% | +72.3% | +22.4% | +36.0% | +94.1% | |
| – | +1,454.1% | +42.4% | -36.9% | -72.3% | +770.7% | -59.1% | +333.4% | -9.2% | -29.3% | +167.9% | +52.8% | |
| – | +243.8% | -49.0% | -0.7% | -14.1% | +121.7% | -63.9% | +829.0% | +76.3% | +23.7% | +34.1% | +95.3% | |
| – | +40.5% | -16.1% | +9.8% | +26.8% | +26.1% | +14.8% | +69.8% | +21.3% | -14.5% | -19.4% | -4.9% | |
| – | +74.9% | -13.8% | +23.8% | +111.8% | +25.8% | +65.3% | +84.3% | +27.7% | +37.8% | +26.8% | +38.1% | |
| – | +44.8% | -15.8% | +11.9% | +41.4% | +26.0% | +32.4% | +71.6% | +26.0% | +4.3% | +2.4% | +16.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.0% | +24.8% | +32.0% | +7.1% | +29.6% | +21.9% | +308.9% | +67.1% | +9.2% | -9.0% | -19.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.1% | +19.6% | +30.9% | -72.7% | +420.9% | +23.1% | -83.6% | +21.3% | -88.7% | +521.6% | +83.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +2,614.3% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.